?s Abstract): Endostatin (ES), a C-terminal fragment of collagen XVIII has been shown to markedly inhibit growth factor mediated endothelial cell migration, proliferation, and tubule formation but has not been explored in epithelial cells. ES is present in embryonic kidney and is also made by ureteric bud cells. The preliminary data described in this proposal reveal that ES binds to epithelial cells and inhibits HGF stimulated migration and branching morphogenesis of individual cells in collagen gel matrix. In addition, ES inhibited branching of ureteric bud in an ex-vivo culture, indicating that ES may be important in the development of the UB and hence kidney. At present the mechanism of ES?s effect is unknown. This proposal is designed to explored the mechanism of ES?s action in epithelial cells by examining various signaling pathways such at MAPK, PI13-kinase and PLC gamma, known to be critical in epithelial morphogenesis. In addition, the role of ES in UB development will be explored using an ex-vivo UB culture set up.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32DK061182-01
Application #
6447271
Study Section
General Medicine B Study Section (GMB)
Program Officer
Rankin, Tracy L
Project Start
2001-05-11
Project End
Budget Start
2001-05-11
Budget End
2002-05-10
Support Year
1
Fiscal Year
2001
Total Cost
$47,348
Indirect Cost
Name
Yale University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520